Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) Receives $10.00 Average PT from Analysts
Shares of Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH – Get Free Report) have received a consensus recommendation of “Buy” from the seven brokerages that are currently covering the firm, Marketbeat Ratings reports. Five analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average 12 […]
Shares of Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH – Get Free Report) have received a consensus recommendation of “Buy” from the seven brokerages that are currently covering the firm, Marketbeat Ratings reports. Five analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average 12 […]
